Search

Your search keyword '"CCA - Target Discovery ' showing total 166 results

Search Constraints

Start Over You searched for: Author "CCA - Target Discovery Remove constraint Author: "CCA - Target Discovery Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
166 results on '"CCA - Target Discovery '

Search Results

1. Bortezomib before and after high-dose therapy in myeloma

2. A chemical screen for medulloblastoma identifies quercetin as a putative radiosensitizer

3. Feasibility of cell-free circulating tumor DNA testing for lung cancer

4. Targeting Macrophages Sensitizes Chronic Lymphocytic Leukemia to Apoptosis and Inhibits Disease Progression

5. Targetable genetic features of primary testicular and primary central nervous system lymphomas

6. Applications of molecular diagnostics for personalized treatment of head and neck cancer: state of the art

7. Moving towards personalised therapy in head and neck squamous cell carcinoma through analysis of next generation sequencing data

8. An immediate, single intravesical instillation of mitomycin C is of benefit in patients with non-muscle-invasive bladder cancer irrespective of prognostic risk groups

9. Position statement on radiopharmaceutical production for clinical trials

10. Spinal cord stimulation as adjuvant during chemotherapy and reirradiation treatment of recurrent high-grade gliomas

11. Influence of health insurance status on paediatric non-Hodgkin's lymphoma treatment in Kenya

12. Better to be alone than in bad company:The antagonistic effect of cisplatin and crizotinib combination therapy in non-small cell lung cancer

13. hENT-1 Expression and Localization Predict Outcome After Adjuvant Gemcitabine in Resected Cholangiocarcinoma Patients

14. Investigating miRNA-mRNA regulatory networks using crosslinking immunoprecipitation methods for biomarker and target discovery in cancer

15. Integrated in vivo genetic and pharmacologic screening identifies co-inhibition of EGRF and ROCK as a potential treatment regimen for triple-negative breast cancer

18. Concomitant targeting of programmed death-1 (PD-1) and CD137 improves the efficacy of radiotherapy in a mouse model of human BRAFV600-mutant melanoma

19. The MEK1/2 Inhibitor Pimasertib Enhances Gemcitabine Efficacy-Letter

20. On the pharmacogenetics of non-small cell lung cancer treatment

21. Multifactorial resistance to aminopeptidase inhibitor prodrug CHR2863 in myeloid leukemia cells: down-regulation of carboxylesterase 1, drug sequestration in lipid droplets and pro-survival activation ERK/Akt/mTOR

22. Optimization of drug combinations using Feedback System Control

23. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

25. Systemically administered AAV9-sTRAIL combats invasive glioblastoma in a patient-derived orthotopic xenograft model

26. New developments in the management of non-small-cell lung cancer, focus on rociletinib: what went wrong?

27. Targeting Serglycin Prevents Metastasis in Murine Mammary Carcinoma

29. Tissue distribution of crizotinib and gemcitabine combination in a patient-derived orthotopic mouse model of pancreatic cancer

30. Using RNA-sequencing to detect novel splice variants related to drug resistance in in vitro cancer models

31. Valproate in adjuvant glioblastoma treatment

32. Tumor cell resistance to antiangiogenic receptor tyrosine kinase inhibitors

33. Advances in purine and pyrimidine metabolism in health and diseases

34. FOLFIRINOX and translational studies: Towards personalized therapy in pancreatic cancer

35. External Beam Radiotherapy of Recurrent Glioma: Radiation Tolerance of the Human Brain

36. Early Magnesium Treatment after Aneurysmal Subarachnoid Hemorrhage : Individual Patient Data Meta-Analysis

37. SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype

38. Tumour control by whole brain irradiation of anti-VEGF-treated mice bearing intracerebral glioma

39. Inflammatory cells and immune microenvironment in malignant lymphoma

40. The role of the p53 pathway in the treatment of follicular lymphoma

41. miR-129-3p controls centrosome number in metastatic prostate cancer cells by repressing CP110

42. Additional Value of Intra-Aneurysmal Hemodynamics in Discriminating Ruptured versus Unruptured Intracranial Aneurysms

43. Human Papillomavirus Type–Specific 18-Month Risk of High-Grade Cervical Intraepithelial Neoplasia in Women with a Normal or Borderline/Mildly Dyskaryotic Smear

44. Mechanisms and effects of loss of human leukocyte antigen class II expression in immune-privileged site-associated B-cell lymphoma

45. Single-assay combination of Epstein-Barr Virus (EBV) EBNA1- and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients

46. Development of a General-Primer-PCR-Reverse-Line-Blotting System for Detection of Beta and Gamma Cutaneous Human Papillomaviruses

47. Concordance of specific human papillomavirus types in sex partners is more prevalent than would be expected by chance and is associated with increased viral loads

48. Absence of caspase 3 activation in neoplastic cells of nasopharyngeal carcinoma biopsies predicts rapid fatal outcome

49. Role of Sexual Behavior in the Acquisition of Asymptomatic Epstein-Barr Virus Infection

50. Expression and analysis of the Epstein-Barr virus BARF1-encoded protein from a tetracycline-regulatable adenovirus system

Catalog

Books, media, physical & digital resources